All News #Library
Biotech
Charm Therapeutics Advances Chm-029 for Acute Myeloid Leukaemia
13 Nov 2025 //
GLOBENEWSWIRE
CHARM Therapeutics Names Dr Erkut Bahceci Chief Medical Officer
08 Sep 2025 //
GLOBENEWSWIRE
CHARM Secures $80M Series B for Menin Inhibitor AML Development
02 Sep 2025 //
GLOBENEWSWIRE
CHARM Therapeutics Appoints Dr. Beverley Carr As Chief Officer
10 Sep 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support